India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Cervical sarcoma can also be cancerous If it looks like a piece of meat or a girkha on any part of the body, it is known as a poko of wealth in the village. Some people may not even consider these girches as lumps of fat or muscles that have grown from exercise. Do not remain silent when such suspicious dalla or girkha come. Because some of these lumps of meat can be cancer like sarcoma, not normal. What is sarcoma cancer? Sarcoma is a type of cancer, which can be bone, joint, muscle. This cancer cell develops rapidly in the soft cells of the bone. Initially, this cancer develops in 'connective tissue' (tissue connecting two organs). Then gradually other areas start spreading. This cancer then spreads to the lungs. This cancer is considered rare but very deadly. Because there are more than 70 types of this cancer. Out of which two main types are soft tissue sarcoma and bone sarcoma. Which part of the body is more likely to develop sarcoma cancer? This cancer can occur anywhere...